0000950170-24-008802.txt : 20240130
0000950170-24-008802.hdr.sgml : 20240130
20240130160109
ACCESSION NUMBER: 0000950170-24-008802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240126
FILED AS OF DATE: 20240130
DATE AS OF CHANGE: 20240130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sukenick Scott
CENTRAL INDEX KEY: 0001722886
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36365
FILM NUMBER: 24578101
MAIL ADDRESS:
STREET 1: 101 HUDSON STREET, SUITE 3610
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCYNEXIS INC
CENTRAL INDEX KEY: 0001178253
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562181648
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
BUSINESS PHONE: 201-884-5485
MAIL ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
4
1
ownership.xml
4
X0508
4
2024-01-26
0001178253
SCYNEXIS INC
SCYX
0001722886
Sukenick Scott
1 EVERTRUST PLAZA
13TH FLOOR
JERSEY CITY
NJ
07302
false
true
false
false
Chief Legal Officer
false
Common Stock
2024-01-26
4
A
false
143675
0
A
351374
D
Employee Stock Option (Right to Buy)
1.86
2024-01-26
4
A
false
215515
0
A
2034-01-25
Common Stock
215515
215515
D
Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024.
Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares).
1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024.
/s/ Robert F. Joyce Jr., by Power of Attorney
2024-01-30